Table 2.
No Revascularization, n = 6999 | Revascularization, n = 89 000 | P Value | |
---|---|---|---|
Patient demographics, % | |||
Age, ya | 77 (64, 85) | 66 (55, 78) | <0.0001 |
Male sex | 48.0 | 60.5 | <0.0001 |
Race | |||
White | 57.5 | 74.7 | <0.0001 |
Black | 8.1 | 8.3 | |
Hispanic | 9.7 | 7.5 | |
Other | 15.1 | 2.9 | |
CAD | 24.2 | 17.0 | <0.0001 |
Prior MI | 24.4 | 21.2 | <0.0001 |
Prior CABG | 2.8 | 2.4 | 0.0375 |
Prior PCI | 1.7 | 3.7 | <0.0001 |
DM | 37.1 | 32.0 | <0.0001 |
Smoking | 18.6 | 29.5 | <0.0001 |
Hyperlipidemia | 36.8 | 46.0 | <0.0001 |
Hypertension | 70.6 | 68.0 | <0.0001 |
PVD | 10.3 | 8.7 | <0.0001 |
Prior stroke | 13.1 | 9.0 | <0.0001 |
HF | 28.5 | 14.1 | <0.0001 |
COPD or asthma | 19.2 | 13.3 | <0.0001 |
Renal insufficiency | 16.6 | 9.0 | <0.0001 |
BMI ≥30 kg/m2 | 20.9 | 30.3 | <0.0001 |
Payment source, % | |||
Medicare | 41.9 | 28.4 | <0.0001 |
Medicaid | 13.8 | 6.2 | |
Other | 32.2 | 42.7 | |
Uninsured | 4.7 | 9.0 | |
Presentation data | |||
SBP, mm Hga | 135 (115, 156) | 138 (119, 158) | <0.0001 |
DBP, mm Hga | 74 (62, 87) | 77 (65, 90) | <0.0001 |
Total cholesterol, mg/dLa | 159 (130, 194) | 167 (138, 199) | <0.0001 |
LDL, mg/dLa | 92 (68, 119) | 99 (75, 127) | <0.0001 |
Triglycerides, mg/dLa | 109 (77, 158) | 122 (84, 182) | <0.0001 |
HbA1c, %a | 7.1 (6.3, 8.2) | 7.3 (6.4, 8.8) | 0.0088 |
Hospital facilities | |||
Academic, % | 51.0 | 60.9 | <0.0001 |
No. of bedsa | 203 (101, 279) | 367 (265, 530) | <0.0001 |
Hospital location, % | |||
Urban | 57.7 | 95.0 | <0.0001 |
Rural | 42.3 | 5.0 | |
Hospital region, % | |||
West | 32.9 | 25.9 | <0.0001 |
South | 28.0 | 31.2 | |
Midwest | 5.6 | 28.1 | |
Northeast | 33.5 | 14.8 | |
Medications on admission, % | |||
None | 1.3 | 2.0 | <0.0001 |
ASA | 19.6 | 14.5 | 0.3403 |
β‐Blocker | 9.9 | 6.2 | <0.0001 |
ACEI | 14.0 | 9.9 | 0.0150 |
ARB | 6.5 | 4.0 | <0.0001 |
Other antiplateletb | 7.7 | 5.7 | 0.4665 |
CCB | 6.6 | 4.7 | 0.2113 |
Nitrates | 5.1 | 2.5 | <0.0001 |
Statins | 17.2 | 13.5 | 0.0747 |
Abbreviations: ACEI, angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor blocker; ASA, aspirin; BMI, body mass index; CABG, coronary artery bypass grafting; CAD, coronary artery disease; CCB, calcium channel blocker; CI, confidence interval; COPD, chronic obstructive pulmonary disease; DBP, diastolic blood pressure; DM, diabetes mellitus; HbA1c, glycated hemoglobin; HF, heart failure; LDL, low‐density lipoprotein cholesterol; MI, myocardial infarction; OR, odds ratio; PCI, percutaneous coronary intervention; PVD, peripheral vascular disease; SBP, systolic blood pressure; TIA, transient ischemic attack.
Continuous variables are expressed as median (25th, 75th percentile). b Excluding ASA.